Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: HPACD

August 3, 2022 CD as API / Pharma applications

HPaCD against Alzheimer Disease

HP-beta-cyclodextrin (HPbCD) is currently in clinical trials against Niemann-Pick Disease Type C (NPC) and Alzheimer’s Disease (AD) and these trials

Continue reading

December 22, 2021 CD as API / Pharma applications

Alpha-cyclodextrin and Hydroxytyrosol against SARS-CoV-2 infection

In the last year, the Cyclodextrin News reported on an oral spray containing alpha-cyclodextrin and hydroxytyrosol developed by Italian researchers

Continue reading

November 22, 2021 Uncategorized

Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation

A patent application by Knut M. Wittkowski (ASDERA LLC, US) entitled “Use of cyclodextrins in diseases and disorders involving phospholipid

Continue reading

August 30, 2018 CD as API / Pharma applications

Different cyclodextrins to treat NPC

If you are following advances in the re-discovery of cyclodextrins as APIs, there is quite a race among the candidates

Continue reading

Recent Posts

  • Methanol detection by film strips containing CD polymer
  • Electrospun nanofibrous membrane functionalized with dual drug-cyclodextrin inclusion complexes as otic formulations for the potential treatment of otitis externa
  • Rapid Adsorption of Indoor Low-Concentration Formaldehyde by β-Cyclodextrin-Based Porous Organic Polymers
  • Emulsions synergistically stabilized by γ-cyclodextrin/sodium caseinate/alginate for food applications
  • Hyaluronic acid-cyclodextrin conjugate encapsulating paeonol for treatment of atopic dermatitis

Tags

antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis Trappsol wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (29)
  • CD as API (182)
  • CD derivatives (233)
  • Cosmetics and toilettry (19)
  • Drug delivery (360)
  • E-ducation (49)
  • Environmental (63)
  • Events (151)
  • Food (105)
  • Gene delivery (9)
  • In Hungarian (4)
  • Life sciences (8)
  • Non-pharma applications (173)
  • Other industrial use (53)
  • Pharma applications (605)
  • Supramolecular systems (20)
  • Uncategorized (34)

Top Posts

  • FDA Approved Development of VAR 200 for Treatment of FSGS
  • How air fresheners work?
  • Methanol detection by film strips containing CD polymer
  • HPaCD against Alzheimer Disease
  • Ozone storage in solid form by cyclodextrins
  • Comparison of Selective Relaxant Binding Agent Adamgammadex Sodium with Sugammadex for Reversing Rocuronium-Induced Deep Neuromuscular Block
  • Novel β-cyclodextrin Polyurethane Materials with Antibiotic Activity
  • Eurocarb21 postponed to 2023
  • International Cyclodextrin Symposium postponed to 2022
  • Hyaluronic acid-cyclodextrin conjugate encapsulating paeonol for treatment of atopic dermatitis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 474 other subscribers
 

Loading Comments...